Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Kakatiya University Pharma faculty lauded for bringing global recognition to department
Director of Aurobindo Pharma M. Madan Mohan Reddy observed that the true strength of a college lies not in its infrastructure but in the quality of teaching and the creativity of its students. He lauded the Pharmacy Department of Kakatiya…
Aurobindo Pharma arm terminates biosimilar pact with U.S. firm BioFactura
Aurobindo Pharma subsidiary CuraTeQ Biologics and U.S. firm BioFactura have terminated their agreement relating to BFI-751, a proposed biosimilar to Janssen Biotech's Stelara (Ustekinumab). The decision is aligned with CuraTeQ's strategic portfolio…
'Pharma' series review: Despite strong performances and solid premise, the narrative misses the mark
There is a scene in one of the first couple of episodes of Pharma (streaming on JioHotstar) where a senior pharmaceutical industry executive explains how their business works. That medicines for one condition might cause a side-effect, for which…
Fake rabies vaccine available in India since 2023, claims Australia: Pharma co refutes charges
The Australian health department has raised an alert against a leading Indian anti-rabies vaccine, stating that counterfeits have been circulating in India since November 2023. The alert urged people who received the vaccine Abhayrab to reach out…
Australia issues advisory on counterfeit anti-rabies vaccine in India; pharma refutes charges
Indian Immunologicals Limited (IIL), one of India's leading vaccine manufacturers, has issued a clarification on Saturday (December 27, 2025) regarding recent reports surrounding its human anti-rabies vaccine, Abhayrab. In it's statement it said…
Nuvectis Pharma (NASDAQ:NVCT) Stock Price Up 0.5% - Here's Why
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report)'s stock price rose 0.5% on Friday. The company traded as high as $7.91 and last traded at $7.75. Approximately 22,642 shares changed hands during mid-day trading, a decline of 76% from the…
Rice Hall James & Associates LLC Trims Stock Holdings in Ascendis Pharma A/S $ASND
Rice Hall James & Associates LLC lowered its stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 8.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned…
Singapore DPR For Future City
Hyderabad: The state government has roped in Singapore-based global consultancy Surbana Jurong to prepare the Detailed Project Report (DPR) for the development of Bharat Future City on the city outskirts, spread over 30,000 acres in its core phase…
BTech in Chemical Engineering vs BTech in Industrial Chemistry: What will you choose?
Every year, after finishing Class 12 exams, many students who love Chemistry find themselves at big crossroads – deciding whether to pursue a BTech in Industrial Chemistry or a BTech in Chemical Engineering. As an educator who has guided…
Seven steps rich households will take next year to maximise their cash
When it comes to tax-efficient financial planning, paying attention to what the very wealthy do can reap rewards. Those with complicated tax affairs and financial advisers on hand know how to maximise their tax allowances and make use of valuable…
10 AI Predictions For 2026
Anthropic will go public. OpenAI will not. Details of SSI's research and technology will leak to the public. The big labs will make meaningful adjustments to their research roadmaps as a result. China's domestic AI chip sector will make significant…
From Hollywood Heartthrob to Persona Non Grata: Ashton Kutcher's Desperate Bid to Claw Back Fame After Masterson and Diddy Scandals
Ashton Kutcher has largely faded from public view in recent years amid a series of controversies that reshaped his public image, RadarOnline.com can report. The 47-year-old actor made just one red carpet appearance in 2025, attending an event in…
Growth Stocks To Consider - December 27th
Prologis Stock Surges: Why the Rally May Continue Prologis, Teledyne Technologies, Hamilton Lane, Ascendis Pharma A/S, and Canopy Growth are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are…
Greenwood Capital Associates LLC Raises Position in Teva Pharmaceutical Industries Ltd. $TEVA
Greenwood Capital Associates LLC increased its position in shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 17.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The…
Is the 'health for all' campaign on track?: Explained
With a population of 146 crore, India's health challenges are growing too. It already faces an avalanche of non-communicable diseases, resurgent infectious diseases, climate change-related issues, concerns relating to quality control in the…
Receive a Daily briefing on Pharma Industry News
Get Started